Picard Medical, Inc.
PMI
$7.60
$0.000.00%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -68.69% | 1.21% | -2.22% | -63.40% | 39.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -68.69% | 1.21% | -2.22% | -63.40% | 39.44% |
| Cost of Revenue | -16.62% | -63.86% | 17.73% | -56.84% | -36.39% |
| Gross Profit | -144.36% | 112.24% | -60.62% | 36.01% | 290.33% |
| SG&A Expenses | 4.58% | -30.81% | 18.67% | 35.39% | -21.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.36% | -34.56% | 24.77% | -6.69% | -18.03% |
| Operating Income | -73.40% | 39.56% | -31.99% | -29.80% | 42.91% |
| Income Before Tax | -183.01% | -47.70% | -88.86% | -38.13% | 41.74% |
| Income Tax Expenses | -- | -650.00% | -- | -- | -- |
| Earnings from Continuing Operations | -184.60% | -47.50% | -88.86% | -38.13% | 41.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -184.60% | -47.50% | -88.86% | -38.13% | 41.74% |
| EBIT | -73.40% | 39.56% | -31.99% | -29.80% | 42.91% |
| EBITDA | -85.20% | 38.78% | -36.58% | -36.47% | 44.66% |
| EPS Basic | -141.60% | -43.18% | -77.14% | -33.72% | 33.56% |
| Normalized Basic EPS | -182.37% | -47.71% | -88.84% | -38.15% | 41.76% |
| EPS Diluted | -141.60% | -43.18% | -77.14% | -33.72% | 33.56% |
| Normalized Diluted EPS | -182.37% | -47.71% | -88.84% | -38.15% | 41.76% |
| Average Basic Shares Outstanding | 0.25% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.25% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |